157 related articles for article (PubMed ID: 27562032)
21. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
[TBL] [Abstract][Full Text] [Related]
22. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.
de Lind van Wijngaarden RA; Hauer HA; Wolterbeek R; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Hagen EC; Bruijn JA; Bajema IM
J Am Soc Nephrol; 2006 Aug; 17(8):2264-74. PubMed ID: 16825335
[TBL] [Abstract][Full Text] [Related]
23. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
24. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis.
Neumann I; Kain R; Regele H; Soleiman A; Kandutsch S; Meisl FT
Nephrol Dial Transplant; 2005 Jan; 20(1):96-104. PubMed ID: 15546891
[TBL] [Abstract][Full Text] [Related]
25. Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea.
Lee SW; Yu MY; Baek SH; Ahn SY; Kim S; Na KY; Chae DW; Chin HJ
J Korean Med Sci; 2016 Apr; 31(4):542-6. PubMed ID: 27051237
[TBL] [Abstract][Full Text] [Related]
26. The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis.
Kristensen T; Gregersen JW; Krag SR; Ivarsen P
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S105-10. PubMed ID: 27241586
[TBL] [Abstract][Full Text] [Related]
27. Relationship between serum C3/C4 ratio and prognosis of immunoglobulin A nephropathy based on propensity score matching.
Zhang Y; Duan SW; Chen P; Yin Z; Wang Y; Cai GY; Chen XM
Chin Med J (Engl); 2020 Mar; 133(6):631-637. PubMed ID: 32068601
[TBL] [Abstract][Full Text] [Related]
28. Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy.
Cohen BA; Clark WF
Am J Kidney Dis; 2000 Nov; 36(5):914-24. PubMed ID: 11054347
[TBL] [Abstract][Full Text] [Related]
29. Relationship between Renal Damage and Serum Complement C3 in Children with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Zhang P; Yang X; He X; Hu J; Gao CL; Xia ZK
Nephron; 2021; 145(6):633-641. PubMed ID: 34198299
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement.
Rihova Z; Jancova E; Merta M; Rysava R; Reiterova J; Zabka J; Tesar V
Kidney Blood Press Res; 2005; 28(3):144-52. PubMed ID: 15908752
[TBL] [Abstract][Full Text] [Related]
31. Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis.
Hakroush S; Tampe D; Baier E; Kluge IA; Ströbel P; Tampe B
J Autoimmun; 2022 Dec; 133():102924. PubMed ID: 36209693
[TBL] [Abstract][Full Text] [Related]
32. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
Shah S; Havill J; Rahman MH; Geetha D
Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
[TBL] [Abstract][Full Text] [Related]
33. Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.
Liu J; Xie J; Zhang X; Tong J; Hao X; Ren H; Wang W; Chen N
Sci Rep; 2017 Jun; 7(1):4095. PubMed ID: 28642464
[TBL] [Abstract][Full Text] [Related]
34. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
35. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH
Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945
[TBL] [Abstract][Full Text] [Related]
36. An index for renal outcome in ANCA-associated glomerulonephritis.
Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
[TBL] [Abstract][Full Text] [Related]
37. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
[TBL] [Abstract][Full Text] [Related]
38. The clinical course of ANCA small-vessel vasculitis on chronic dialysis.
Lionaki S; Hogan SL; Jennette CE; Hu Y; Hamra JB; Jennette JC; Falk RJ; Nachman PH
Kidney Int; 2009 Sep; 76(6):644-51. PubMed ID: 19536079
[TBL] [Abstract][Full Text] [Related]
39. The level of urinary α1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis.
Ohashi N; Ishigaki S; Kitajima K; Tsuji N; Isobe S; Iwakura T; Ono M; Fujikura T; Tsuji T; Sakao Y; Kato A; Yasuda H
Clin Exp Nephrol; 2015 Oct; 19(5):851-8. PubMed ID: 25528655
[TBL] [Abstract][Full Text] [Related]
40. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.
Bakoush O; Segelmark M; Torffvit O; Ohlsson S; Tencer J
Nephrol Dial Transplant; 2006 May; 21(5):1263-9. PubMed ID: 16449276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
